Home LiteratureArticle Details
PMID: 8394378 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems.

Journal of clinical microbiology ·Vol. 31 ·No. 7 ·1993-07-00 ·Pages 1870-5

Clabots CR, Johnson S, Bettin KM, Mathie PA, Mulligan ME, Schaberg DR, Peterson LR, Gerding DN

Abstract

A HindIII restriction endonuclease analysis (REA) typing system for total genomic Clostridium difficile DNA including a rapid and efficient method of DNA extraction and a scheme for organizing unique electrophoretic DNA band patterns was developed. REA typing was performed by two extraction methods for 1,965 C. difficile isolates obtained from patients with symptomatic C. difficile disease, asymptomatic patients who were C. difficile culture positive, and environmental surfaces. This isolate collection yielded 206 unique REA types, which were organized into 75 groups. A reference strain representing each unique REA type was chosen for DNA band pattern comparisons, cytotoxin testing, and plasmid analysis. The DNA band patterns utilizing a guanidine thiocyanate-EDTA-Sarkosyl DNA extraction method were 94% reproducible, while the original and sporadically problematic diethyl pyrocarbonate-sodium dodecyl sulfate DNA extraction method was 98% reproducible when readable patterns were obtained. Reference strains from 43 of the 75 groups were cytotoxin positive, 28 groups were cytotoxin negative, and 4 groups included both toxigenic and nontoxigenic strains. Cytotoxicity of isolates with a particular REA type was always consistent with the toxicity of the reference strain for that type. REA typing was able to discriminate strain differences within types identified by the immunoblot (89 isolates), bacteriophage-bacteriocin (44 isolates), and ribotyping (23 isolates) methods. REA typing is a sensitive, discriminating, reproducible, and rapid method for differentiating C. difficile strains and is suitable for large-scale epidemiologic studies.

MeSH Terms
Bacterial Typing Techniques/statistics & numerical data Clostridioides difficile/classification,genetics,isolation & purification DNA Restriction Enzymes DNA, Bacterial/genetics Enterocolitis, Pseudomembranous/epidemiology,microbiology Epidemiologic Methods Evaluation Studies as Topic Humans Prohibitins Sensitivity and Specificity
Chemicals
DNA, Bacterial PHB2 protein, human Prohibitins DNA Restriction Enzymes
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Clabots C R
Infectious Disease Section, Minneapolis Veterans Affairs Medical Center, Minnesota.
Johnson S
Bettin K M
Mathie P A
Mulligan M E
Schaberg D R
Peterson L R
Gerding D N
References (26)
26 references, click to expand
  1. Selective and differential medium for isolation of Clostridium difficile.
    J Clin Microbiol. 1979 Feb;9(2):214-9 PMID: 429542
  2. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.
    J Infect Dis. 1992 Sep;166(3):561-7 PMID: 1323621
  3. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  4. Bacteriophage and bacteriocin typing scheme for Clostridium difficile.
    J Clin Microbiol. 1983 Jun;17(6):1148-52 PMID: 6874905
  5. Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies.
    Lancet. 1984 Apr 28;1(8383):935-8 PMID: 6143871
  6. Role of DNase in recovery of plasmid DNA from Clostridium perfringens.
    Appl Environ Microbiol. 1984 Jul;48(1):178-81 PMID: 6089664
  7. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.
    Arch Intern Med. 1986 Jan;146(1):95-100 PMID: 3942469
  8. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.
    Am J Clin Pathol. 1986 Aug;86(2):208-11 PMID: 3739972
  9. Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea.
    J Clin Microbiol. 1987 Apr;25(4):751-3 PMID: 3033017
  10. Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion.
    Ear Hear. 1987 Jun;8(3):151-6 PMID: 3609510
  11. Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile.
    J Clin Microbiol. 1987 Nov;25(11):2168-72 PMID: 2826534
  12. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.
    J Infect Dis. 1988 Feb;157(2):280-6 PMID: 2447202
  13. Association between production of toxins A and B and types of Clostridium difficile.
    J Clin Pathol. 1987 Dec;40(12):1397-401 PMID: 3123524
  14. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile.
    J Clin Microbiol. 1988 Jan;26(1):41-6 PMID: 3343314
  15. Serotyping of Clostridium difficile.
    J Clin Microbiol. 1988 Mar;26(3):426-8 PMID: 2833528
  16. Acquisition of Clostridium difficile from the hospital environment.
    Am J Epidemiol. 1988 Jun;127(6):1289-94 PMID: 2835900
  17. Characterization of a nosocomial Clostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing.
    J Infect Dis. 1988 Oct;158(4):731-6 PMID: 2844914
  18. DNA fingerprints of Streptococcus pyogenes are M type specific.
    J Infect Dis. 1988 Dec;158(6):1317-23 PMID: 3058817
  19. Nosocomial acquisition of Clostridium difficile infection.
    N Engl J Med. 1989 Jan 26;320(4):204-10 PMID: 2911306
  20. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.
    J Infect Dis. 1989 Feb;159(2):340-3 PMID: 2915158
  21. Nosocomial Clostridium difficile colonisation and disease.
    Lancet. 1990 Jul 14;336(8707):97-100 PMID: 1975332
  22. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.
    Infect Immun. 1991 Jul;59(7):2456-62 PMID: 2050409
  23. Evaluation of cycloserine-cefoxitin-fructose agar and cycloserine-cefoxitin-fructose broth for recovery of Clostridium difficile from environmental sites.
    J Clin Microbiol. 1991 Nov;29(11):2633-5 PMID: 1774277
  24. Ribotyping of coagulase-negative staphylococci with special emphasis on intraspecific typing of Staphylococcus epidermidis.
    J Clin Microbiol. 1992 Apr;30(4):817-23 PMID: 1315335
  25. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
    Ann Intern Med. 1992 Aug 15;117(4):297-302 PMID: 1322075
  26. A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
    Nucleic Acids Res. 1979 Nov 24;7(6):1513-23 PMID: 388356
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1993-07-00
Pages
1870-5
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC265648
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com